Petri Hyytiä

Petri Hyytiä

Auto-generated profile, based on publicly available information

Petri Hyytiä

Department of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2005 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PBPia Bäckström
Pia Bäckström
PHPetri Hyytiä
Petri Hyytiä

8 February 2006 in Neuropsychopharmacology
Verified
Journal Article
Closed access
AHAnita C Hansson
Anita C Hansson
FBFrancisco J Bermudez-Silva
Francisco J Bermudez-Silva
HMHanna Malinen
Hanna Malinen
PHPetri Hyytiä
Petri Hyytiä
ISIrene Sanchez-Vera
Irene Sanchez-Vera
MHMarkus Heilig
Markus Heilig

1 October 2015 in Pharmacological Reviews
Verified
Journal Article
Closed access
EKEsa R. Korpi
Esa R. Korpi
BHBjørnar Den Hollander
Bjørnar Den Hollander
UFUsman Farooq
Usman Farooq
EVElena Vashchinkina
Elena Vashchinkina
RRRamamoorthy Rajkumar
Ramamoorthy Rajkumar
Gavin Stewart DaweGavin Stewart Dawe
Gavin Stewart Dawe
Adaptation of the nervous system to different chemical and physiologic conditions is important for the homeostasis of brain processes and for learning and remembering appropriate responses to challenges. Although processes such as tolerance and dependence to various drugs of abuse have been known for a long time, it was recently discovered that even a single pharmacologically relevant dose of various drugs of abuse induces neuroplasticity in selected neuronal populations, such as the dopamine neurons of the ventral tegmental area, which persist long after the drug has been excreted. Prolonged (self-) administration of drugs induces gene expression, neurochemical, neurophysiological, and structural changes in many brain cell populations. These region-specific changes correlate with addiction, drug intake, and conditioned drugs effects, such as cue- or stress-induced reinstatement of drug seeking. In rodents, adolescent drug exposure often causes significantly more behavioral changes later in adulthood than a corresponding exposure in adults. Clinically the most impairing and devastating effects on the brain are produced by alcohol during fetal development. In adult recreational drug users or in medicated patients, it has been difficult to find persistent functional or behavioral changes, suggesting that heavy exposure to drugs of abuse is needed for neurotoxicity and for persistent emotional and cognitive alterations. This review describes recent advances in this important area of research, which harbors the aim of translating this knowledge to better treatments for addictions and related neuropsychiatric illnesses.